J Biol Chem, Vol. 275, Issue 5, 3042-3050, February 4, 2000
Conformational Transitions of the Three Recombinant Domains of
Human Serum Albumin Depending on pH*
Michael
Dockal
§,
Daniel C.
Carter¶, and
Florian
Rüker
From the
Institute of Applied Microbiology,
University of Agricultural Sciences, Muthgasse 18, A-1190 Vienna, Austria and ¶ New Century Pharmaceuticals Inc.,
Huntsville, Alabama 35824
 |
ABSTRACT |
Human serum albumin (HSA) is a protein of 66.5 kDa that is composed of three homologous domains, each of which
displays specific structural and functional characteristics. HSA is
known to undergo different pH-dependent structural
transitions, the N-F and F-E transitions in the acid pH region and the
N-B transition at slightly alkaline pH. In order to elucidate the
structural behavior of the recombinant HSA domains as stand-alone
proteins and to investigate the molecular and structural origins of the
pH-induced conformational changes of the intact molecule, we have
employed fluorescence and circular dichroic methods. Here we provide
evidence that the loosening of the HSA structure in the N-F transition
takes place primarily in HSA-DOM III and that HSA-DOM I undergoes a
structural rearrangement with only minor changes in secondary
structure, whereas HSA-DOM II transforms to a molten globule-like state
as the pH is reduced. In the pH region of the N-B transition of HSA, HSA-DOM I and HSA-DOM II experience a tertiary structural
isomerization, whereas with HSA-DOM III no alterations in tertiary
structure are observed, as judged from near-UV CD and fluorescence measurements.
 |
INTRODUCTION |
The albumin molecule is composed of three homologous,
predominantly helical evolutionarily related domains. Each domain is made up of two subdomains, which share a common helical motif. Specific
characteristics, for example the location of the various ligand-binding
sites, were assigned to some of the domains or subdomains in the past
(1, 2). We recently described the production of the three domains of
HSA1 as recombinant proteins,
and we were able to show that they have structural features as well as
ligand binding properties correlating to their specific functionality
in the context of the native protein (3). Clear evidence could be
provided that the primary binding site for hemin is located on HSA-DOM
I and that for diazepam on HSA-DOM III.
Human serum albumin undergoes several transitions in dependence of pH,
the N-F transition between pH 5.0 and 3.5, the F-E transition or acid
expansion below pH 3.5, and the N-B transition between pH 7.0 and 9.0 (1, 2). The acid-induced structural changes of bovine and human serum
albumin have been studied by a wide range of methods (1, 2) and are
characterized by changes in secondary as well as tertiary structure. An
indication for the former is a significant decrease in helical content
observed by far-UV CD measurements which was interpreted by Era
et al. (4, 5) to represent a helix
and a helix
coil transition in the case of the N-F transition. As the pH of an
albumin solution is reduced below 3.5, further unfolding occurs until
about pH 2.5, when the molecule appears to be expanded to the full
extent that is allowed by its disulfide bonding structure. Under
slightly alkaline conditions, between pH 7.0 and 9.0, HSA and BSA
undergo another conformational change, known as the N-B transition. It is more subtle and more gradual in onset and has been proposed to have
physiological importance, similar to the acid-induced transformations
(1, 2). The B isomerization is supposed to be a structural fluctuation,
a loosening of the molecule with loss of rigidity, particularly
affecting the N-terminal region and thereby impacting ligand binding
(6-9).
One way to explore the molecular origins of these transitions is
by using albumin fragments. Attempts have been made in the past to
assign specific roles and contributions of the albumin domains to the
characteristic structural transitions of both HSA and, more frequently,
its closely related bovine homolog, BSA. For many of these studies,
fragments have been used, which had been produced by enzymatic or
chemical cleavage (8-17).
An F-like transformation was observed with a tryptic fragment of bovine
serum albumin (BSA-T377-582), shedding some light on the
nucleation points for the intramolecular changes that occur during this
transition (13). It was shown that this fragment unfolds and abruptly
loses structure at pH 4, whereas fragment BSA-P1-385 does
not do so until pH 3.5 (12), as determined by difference spectroscopic
methods. Domain III of BSA was consequently proposed to have a less
constrained conformation than the rest of the molecule and to expand
through separation of its subunits in the course of the N-F transition.
Bos et al. (17) concluded from their work with two large
fragments of HSA that the conformational change between pH 6.0 and 9.0 of the P-46 fragment (residues 1-387 of HSA) clearly resembles the N-B
transition of albumin, whereas the T-45 fragment (residues 198-585 of
HSA) does not display such a conformational change. However, the choice of fragments used in these studies was dependent on the availability of
suitable cleavage sites and did not necessarily take into account the
natural borders of the domains as they can be defined based on amino
acid sequence and atomic structure.
Based on our previous results on the structure and ligand binding
properties of the three recombinant HSA domains, we report here in a
systematic way on the conformational behavior of these new proteins in
the acidic and slightly alkaline pH region and on their contributions
to the origins of the structural transitions of the native molecule.
For this purpose, fluorescence and CD spectroscopic measurements were
performed depending on pH, and the results are discussed in the context
of the atomic coordinates of HSA.
 |
EXPERIMENTAL PROCEDURES |
Materials--
HSA (essentially free of fatty acids and
globulin) was from Sigma (catalog number A3782). This material was
further purified by size exclusion chromatography over Superdex 200 prep grad (Amersham Pharmacia Biotech) and delipidated by passing over
a Lipidx-1000 column (Canberra-Packard).
The three domains of HSA were cloned, expressed, and purified as has
been described before in detail (3). The domains encompassed the
following amino acid residues of HSA: HSA-DOM I, 1-197; HSA-DOM II,
189-385; HSA-DOM III, 381-585. Due to the restriction site used for
cloning, all domains had Glu-Phe as the N-terminal amino acids. All
other reagents were of analytical grade.
Protein Solutions--
Protein stock solutions were prepared by
dissolving the delipidated proteins in aqua bidest. Protein
concentrations were measured by their absorbance at 278 nm on a
Hewlett-Packard HP8453 spectrophotometer. For HSA, an absorption
coefficient (A278 nm,1 cm0.1%)
of 0.58 was used (8). For HSA-DOM I, HSA-DOM II, and HSA-DOM III,
the absorption coefficients were found to be 0.50, 0.79, and
0.30, respectively (3).
pH-dependent CD Measurements--
Measurements were
made using a Jasco J-600 spectropolarimeter using a 1-mm cell at
25 °C in a thermostated cell holder at a concentration of 4.5 µM in the far-UV region. Scans were made from 250 to 190 nm. The slit width was programmed for a half-bandwidth of 1 nm, and the
dynode voltage never exceeded 0.6 kV. 10 µl of a 100 times
concentrated protein stock solution (in aqua bidest.) were mixed with
990 µl of the corresponding buffer (pH 9.0 to 8.5, 10 mM
boric acid/Borax; pH 8.0 to 5.0, 10 mM sodium phosphate; pH
4.5 to 3.5, 10 mM acetic acid/sodium acetate; pH 3.0 and
less was adjusted with HCl). All spectra were recorded at least twice. After each measurement, the pH was confirmed with a standard pH meter.
The data were expressed as mean residue ellipticity
([
]MRW, degree cm2 dmol
1),
using the mean residue weights of 114.0 g mol
1 for the
intact molecule, 114.9 g mol
1 for HSA-DOM I, 113.2 g
mol
1 for HSA-DOM II, and 113.0 g mol
1 for
HSA-DOM III.
The fractional content of the secondary structure elements of the
proteins was calculated from the far-UV CD spectra using the procedure
of Provencher and co-workers (18, 19) (CONTIN) with a set of 16 reference proteins.
In the near-UV region, measurements were made using a 1-cm cell at
25 °C in a thermostated cell-holder at a protein concentration of 20 µM. Scans were made from 340 to 250 nm. The slit width
was programmed for a half-bandwidth of 1 nm, and the dynode voltage never exceeded 0.4 kV. As above, a 100 times concentrated protein stock
solution was diluted with the desired buffer (pH 9.0, 0.1 M
boric acid/Borax; pH 7.4, 0.1 M sodium phosphate; pH 4.0, 0.1 M acetic acid/sodium acetate; pH 2.0 was adjusted with
HCl) to reach the final protein concentration of 20 µM.
The results are expressed as molar ellipticity ([
], degree
cm2 dmol
1).
pH-dependent Fluorescence
Spectroscopy--
Fluorescence measurements were made with a Hitachi
F-4500 fluorescence spectrometer equipped with a thermostated cell
holder at 25 °C. All spectra were recorded in a 0.5 × 1-cm
stirred cell (0.5 cm at emission and 1 cm at excitation side) with the
excitation and the emission slit width set to 5 nm. For HSA and HSA-DOM
II, which contain only a single tryptophanyl residue (Trp-214), an excitation wavelength of 295 nm was routinely used, to ensure that the
light was absorbed almost entirely by the lone tryptophanyl residue.
HSA-DOM I and HSA-DOM III were excited at 280 nm to record the tyrosyl
emission. pH-dependent experiments were carried out as
described above with a protein concentration of 4.5 µM,
and all spectra were recorded at least twice. Each spectrum was
corrected for buffer base-line fluorescence. After each measurement the pH was controlled with a standard pH meter.
 |
RESULTS |
Far-UV CD--
In order to get information about the secondary
structure of the proteins used in this study, far-UV CD measurements
were performed between 250 and 190 nm depending on the pH. A spectrum for each of the proteins in the native (pH 7.4) and denatured state
(9.5 M urea) is shown in Fig.
1A, demonstrating full
disruption of the secondary structure of all proteins at 9.5 M urea.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
A, far-UV CD spectra of HSA (-),
HSA-DOM I (- - -), HSA-DOM II (-·-), and HSA-DOM III
(-··-) at pH 7.4 and 9.5 M urea, 25 °C,
protein concentration 4.5 µM. B, effect of pH
on the far-UV CD at 222 nm of HSA ( ), HSA-DOM I ( ), HSA-DOM II
( ), and HSA-DOM III ( ) at 25 °C, protein concentration 4.5 µM. The regions of the transitions of HSA are
indicated.
|
|
Fig. 1B presents the ellipticity at 222 nm in the pH range
from 9.0 to 1.5 for the four proteins. Alterations in the ellipticity at this wavelength are a useful probe for visualizing varying
-helical content. The results of the secondary structure resolved analysis are represented in Table I for
pH 9.0, 7.4, 4.0 and 2.5.
View this table:
[in this window]
[in a new window]
|
Table I
Fraction of secondary structural elements of HSA, HSA-DOM I, HSA-DOM
II, and HSA-DOM III estimated by the procedure of Provencher and
Glöckner (CONTIN) (18, 19)
The abbreviations used are: f , fraction of
-helix content; f , fraction of -sheet
content; fR, fraction of remainder structure
elements.
|
|
In the acid pH region from pH 5.0 to 3.5 and further down to pH 2.5, the ellipticity observed with HSA shows a two-step sigmoidal increase,
and calculated helix content (f
) decreases,
whereas sheet structures (f
) increase. These
changes in secondary structure are in accordance with the concept of
the N-F transition followed by the acid expansion (1, 2, 4, 5). A
similar observation is made with HSA-DOM III, which also displays a
characteristic two-step transition correlated with a decrease in
-helical content and a gain in
-sheet structure. However, the two
transitions are clearly split. The onset of the first sigmoidal
transition is shifted to higher pH as compared with HSA, followed by a
second change in the pH region between 3.0 and 2.0. These findings
clearly prove that the N-F transition originates in a structural
loosening at the C-terminal end of the albumin molecule, probably
followed by a separation of domains and subdomains in the course of the acid expansion, as has been suggested before by several authors (1, 2,
13, 15, 16). For HSA-DOM I, a slight increase in [
]222
is observed in the pH region from 5.5 to 3.5, which indicates only a
minor change in secondary structure, whereas below pH 3.5 this domain
shows an acid expansion similar to HSA and HSA-DOM III, which is
further evidence for the disruption of intradomain structure of HSA in
this pH region. By diminishing the pH of a HSA-DOM II solution from 6.0 to 4.0, unexpectedly a sigmoidal decrease in [
]222, is
observed, which is correlated with a slight increase in
-helix
content accompanied by a reduction of
-sheet structure. HSA-DOM II
shows, in contrast to HSA-DOM I and HSA-DOM III, only a slight
increment in ellipticity in the acid expansion region of HSA. Below pH
2.0, the ellipticity of all four proteins investigated is decreased.
This can be interpreted as a gain in secondary structure, as was
observed previously for many proteins in the absence of salt by Goto
et al. (20) and Fink et al. (21).
HSA shows a small increase in the ellipticity at 222 nm in the pH range
from 7.4 to 9.0, indicating a slight reduction of
-helical content
and an increase in
-structural elements, in accordance with the
concept of the well known N-B transition in the absence of added salt
(2, 22). Neither of the recombinant domains exhibits significant
fluctuation in ellipticity between pH 6.0 and 9.0. In this pH region,
only minor changes in secondary structure can therefore be expected,
which is further supported by the data from the secondary structure
resolved analysis.
Tryptophanyl Fluorescence--
HSA has a single tryptophanyl
residue, Trp-214, located in domain II. To examine the conformational
variations around this residue in HSA and HSA-DOM II, fluorescence was
excited at 295 nm, which provides no excitation of tyrosine residues
and therefore neither emission nor energy transfer to the lone indole
side chain.
The pH profiles of the fluorescence intensity and the wavelength at the
respective emission maximum are displayed in Fig. 2A for HSA and HSA-DOM II. The
fluorescence of HSA in the acid pH region exhibited a two-step
decrease, the first from pH 6.0 to 4.5 and the second, more pronounced,
from pH 3.5 to 2.5, representing the N-F and F-E transitions (16, 23,
24). The wavelength maximum of the tryptophanyl fluorescence shifted
from 340 nm at the high pH end of the N-F transition (pH 5.0) to
approximately 332 nm at pH 3.5. By raising the pH of an HSA solution
from 7.4 to 9.0, we observed a slight decrease of
max
and fluorescence intensity (Fig. 2A), which was reported
previously for BSA in the absence of salt (22).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
A, effect of pH on the Trp-214
fluorescence intensity at the emission maximum (left-hand
scale) and emission maximum wavelength (right-hand
scale) of HSA ( ) and HSA-DOM II ( ) at 25 °C, excitation
295 nm, protein concentration 4.5 µM. The regions of the
transitions of HSA are indicated. B, effect of pH on the Tyr
fluorescence intensity at the emission maximum (left-hand
scale) and emission maximum wavelength (right-hand
scale) of HSA-DOM I ( ) and HSA-DOM III ( ) at 25 °C,
excitation 280 nm, protein concentration 4.5 µM. The
regions of the transitions of HSA are indicated.
|
|
At pH 7.4, the fluorescence quantum yield of the tryptophanyl residue
in HSA-DOM II is 2.6-fold lower compared with Trp-214 in the native
molecule, and the emission maximum is shifted from 340 (HSA) to 332 nm
(HSA-DOM II). As the pH is reduced, HSA-DOM II shows a sigmoidal rise
in fluorescence intensity, reaching a maximum increase of 2.4-fold at
pH 4.0. At the onset of this intensity enhancement no change of the
emission maximum is observable, whereas from pH 5.5 to pH 4.0 a
slight decrease of 1 nm can be detected. The pronounced rise in
fluorescence intensity of HSA-DOM II between pH 7.4 and 4.0 coincides
with the secondary structural rearrangement observed by far-UV CD in
the same pH region. At pH 4.0, the tryptophanyl residues of both
HSA-DOM II and HSA have superimposable fluorescence spectra (data not
shown), suggesting that at this pH the tryptophanyl residue in both
proteins has a similar environment.
By further reduction of the pH, the fluorescence intensity and emission
maximum of HSA-DOM II and HSA run nearly parallel, but the diminution
in fluorescence intensity below pH 3.0 followed by the increase below
pH 2.0 is not as pronounced in HSA-DOM II as it is in HSA. Even at pH
2.0, the tryptophanyl residues are not in a solvent-exposed
environment, as indicated by denaturing both proteins with 9.5 M urea, which leads to a red shift of the fluorescence
maximum (349 nm for both proteins) and a reduction of the fluorescence
intensity (data not shown). In the slightly alkaline pH region HSA-DOM
II shows a gain in tryptophanyl fluorescence intensity, which is
accompanied by an increase of the emission maximum.
Tyrosyl Fluorescence--
Since HSA harbors only a single
tryptophanyl residue, which is located in domain II, we investigated
the tyrosyl fluorescence of HSA-DOM I and HSA-DOM III in order to
obtain additional insight into the structural characteristics of these
two proteins. The pH profiles of the fluorescence intensity and the
wavelength at the emission maximum are visualized in Fig.
2B.
In the acidic pH region, HSA-DOM I shows a two-step alteration in
fluorescence intensity. At first, by lowering the pH to 3.5, the
fluorescence increases, which is aligned with a slight, but
significant, decrease in the emission maximum. By further reducing the
pH, the fluorescence intensity rises to a maximum value at pH 2.0;
however, no change in the position of the emission maximum is observed.
The spectra of HSA-DOM I in 9.5 M urea and at pH 2.0 (data
not shown) are nearly superimposable, indicating that the seven tyrosyl
residues in this protein have the same environment at pH 2.0 as in the
fully denaturated state at 9.5 M urea. In the neutral and
slightly alkaline pH range the tyrosyl fluorescence and the position of
the emission maximum of HSA-DOM I show no significant alterations,
which indicates no significant changes in the microenvironments of the
seven tyrosyl residues.
As the pH of the HSA-DOM III solution is reduced to pH 4.0, there is a
sharp sigmoidal decrease in the tyrosyl fluorescence intensity and a
slight increase in the emission maximum, however, by further lessening
of the pH of the solution there is a smooth and continuous increase in
fluorescence intensity. The tyrosyl fluorescence intensity of HSA-DOM
III in the neutral to slightly alkaline pH region decreases, whereas
the emission maximum increases slightly but reproducibly from ~304 nm
at pH 6.0 to ~305 nm at pH 9.0. By raising the pH, a shoulder near
350 nm becomes obvious, which indicates ionization of some tyrosyl side
chains (data not shown) (25).
Near-UV CD--
To study the structural alterations in more
detail, CD measurements in the near-UV region, which infer to tertiary
structure, were performed at specific pH values, and the results are
shown in Fig. 3, A-D, for HSA
and each of the three recombinant domains.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Near-UV CD spectra of HSA
(A), HSA-DOM I (B), HSA-DOM II
(C), and HSA-DOM III (D) at pH 7.4 (-), 9.0 (- -), 4.0 (-·-), 2.0 (-··-), and 9.5 M
urea (····), 25 °C, protein concentration 20 µM.
|
|
The near-UV CD spectra of HSA are shown in Fig. 3A. At pH
7.4, minima at 262 and 268 nm are observed as well as two shoulders near 276 and 283 nm, which is in accordance with previous findings (26-28). By reducing the pH to 4.0 and further to 2.0 there is an
increase in the ellipticity at 262 and 268 nm and a decrease between
290 and 300 nm, denoting loss of tertiary structure in both the N-F
transition and the acid expansion, in agreement with the alterations in
secondary structure and tryptophanyl fluorescence. These findings agree
with results published previously (29, 30). However at pH 2.0 there are
still significant CD signals left, compared with the spectrum at 9.5 M urea, suggesting remaining tertiary structure even at
this low pH. By changing the pH of the HSA solution from 7.4 to 9.0, we
observe a slight gain in the CD signal at 262 and 268 nm, which might
reflect perturbations around the numerous disulfide bridges (22, 30).
In addition, a small reduction in ellipticity in the region between 280 and 300 nm is seen, which was ascribed to changes in the tryptophanyl environment (22, 30) and which is corroborated here by the changes in
tryptophanyl fluorescence that we observed in this pH region.
Fig. 3B presents the near-UV CD spectra of HSA-DOM I. Like
HSA at pH 7.4, two minima at 262 and 268 nm and a shoulder at 276 nm
are seen, and an additional shoulder near 255 nm is evident. Upon
reduction of the pH of the solution to 4.0 the spectrum of HSA-DOM I
exhibits an increase of [
]262 and
[
]268, a flattening of the shoulder at 255 nm, and a
decrease in the region above 280 nm with loss in fine structure. This
is a clear indication for a structural rearrangement of HSA-DOM I in
the pH region of the N-F transition of HSA, which is further emphasized
by the pronounced increase in tyrosyl fluorescence intensity and the shifting emission maximum. By a further decrease of the pH to 2.0, an
overall increase in ellipticity compared with the spectrum at pH 4.0 is
perceivable, indicating further loss of tertiary structure elements of
this domain in the pH region of the F-E transition of HSA. At 9.5 M urea, a dramatic increase in ellipticity was observed.
The difference between the spectrum at pH 2.0 and 9.5 M
urea denotes that even at pH 2.0 some tertiary structural elements are
left. By raising the pH of the HSA-DOM I solution to 9.0, the CD signal
at 262 and 268 nm increases slightly and the shoulder near 255 nm
flattens, whereas there is a decrease in the region above 285 nm,
highlighting the contribution of HSA-DOM I to the N-B transition of
HSA.
The near-UV CD spectra of HSA-DOM II at different pH values and at 9.5 M urea are presented in Fig. 3C. Similar to HSA
the spectrum at pH 7.4 has minima at 262 and 268 nm, shoulders at 276 and 283, and an additional shoulder at 287 nm. As the pH is reduced to
4.0, there is an overall loss in ellipticity below 300 nm, and
additional minima at 282 and 291 nm arise. These alterations in the
near-UV CD spectra of HSA-DOM II provide evidence for major fluctuations in the tertiary structure and may reflect the changes in
the environment of the tryptophanyl residue, which are documented by
the 2.4-fold increase in fluorescence intensity as well as the
secondary structural changes observed by far-UV CD in the same pH
region. At pH 2.0 the ellipticities at 283 and 295 nm are only slightly
increased, whereas the changes at 262 and 268 nm are more pronounced,
indicating further loss in asymmetry around disulfide bridges and/or
aromatic residues. The spectrum of HSA-DOM II in 9.5 M urea
is different in shape compared with that at pH 2.0; however, the signal
strength is similar, denoting that only minor tertiary structure
elements are left at pH 2.0, in contrast to HSA and the other two
domains. By increasing the pH of the solution to 9.0, a slight
enhancement of the ellipticity at 262 and 268 nm is evident. The
shoulder at 287 nm is transformed to a minimum and an additional
shoulder at 295 nm arises. These findings and the changes in the
tryptophanyl fluorescence intensity and emission maximum suggest that
the tertiary structure is changing in the alkaline pH region, whereas
there are only small fluctuations in secondary structure (Fig.
1B).
In Fig. 3D the near-UV CD spectra of HSA-DOM III are shown.
Similar to HSA, minima at 262 and 268 nm and shoulders near 276 and and
near 283 nm are observed at pH 7.4. By reduction of the pH from 7.4 to
4.0, the ellipticity below 295 nm increases, and a loss in fine
structure is detectable in the wavelength region between 295 and 270 nm. As the pH is diminished to 2.0, ellipticities below 310 nm are
further enhanced, however less pronounced than at 9.5 M
urea, providing evidence that even at pH 2.0 some tertiary structure
elements are left. Increasing the pH from 7.4 to 9.0 leads only to
modest changes, which indicates only minor perturbations of tertiary
structure in the pH region of the N-B transition of HSA. This clearly
demonstrates that the major structural rearrangement in the N-B
transition of HSA is not likely to happen in domain III of the native
albumin molecule.
 |
DISCUSSION |
We described previously the production and characterization of the
three recombinant domains of HAS, and we discussed in depth their
potential as models for the albumin molecule with an emphasis on
studying their basic structural features and ligand binding activities
(3). The present study highlights the structural integrity and the
behavior under varying pH conditions of these new proteins in
comparison with intact albumin. Measurements with HSA were used
throughout our experiments as a reference in order to compare all
observations made with the three recombinant domains directly to the
data obtained with the native protein. In general, good agreement was
achieved with published data for HSA.
Far-UV CD--
In the pH region of the N-F transition (pH 5.0 to
3.5), a reduction of helical structure occurs in HSA, whereas the
content of sheet structure increases (Fig. 1B and Table I).
These findings are in accordance with previously published observations
for both HSA and BSA (4, 5, 29-31), where it has been proposed that the N-F transition might represent helix
and helix
coil transitions. In the acid-expansion region (pH 3.5 to 2.5), we found a
further marked reduction in the helix content and an increase in sheet
structure which is in agreement with Era et al. (4, 5) and
Sogami et al. (30). However, in contrast to these publications we did not find a significant increase in random coil
content, and the changes that we observed were not as pronounced as
those found by these authors. Furthermore, the onset of the N-F
transition occurred about 0.5 pH units earlier in our experiments, which could be ascribed to the different buffer systems that were used
in the pH range of the N-F transition. We used acetic acid/sodium acetate in the pH region of 4.5 to 3.5, whereas Era et al.
(4, 5) and Sogami et al. (30) adjusted the pH with HCl in
0.1 M NaCl or KCl. Interaction of undissociated acetic acid
by hydrogen bonding to carboxylic groups of proteins was demonstrated
for BSA and other proteins as revealed by electrophoresis (32-34) and CD (35, 36). Furthermore, Leonard and Foster (37) showed that the pH
profile of the N-F transition of BSA in acetic acid/acetate differs
from that in chloride. In addition, the earlier onset of the N-F
transition of the HSA used in our experiments could be due to
differences in the preparation method, which is known to contribute to
the structural behavior of albumin (38-40) and/or to the absence of
added salt and bound fatty acids, shifting the midpoint of the N-F
transition of BSA to higher pH (41).
A number of interesting observations was made with the HSA domains in
the acid pH range. A high degree of similarity in behavior to the
native protein was observed with HSA-DOM III, which displayed a
two-step transition with a decrease in helical and an increase in sheet
content (Fig. 1B and Table I). However, the two transitions are more distinctly separated from each other than the N-F, and the F-E
transitions are in HSA under our conditions; furthermore, the onset of
the first structural change occurs earlier and that of the second later
than in our control experiments with the native protein. The crystal
structure of HSA strongly suggests at least five interdomain salt
bridges and six hydrogen bondings for domain III at neutral pH. The
fact that HSA-DOM III in its recombinant form is missing these
stabilizing interactions may be an explanation for the earlier onset of
the first and the delay of the second transition in HSA-DOM III. This
notion is further supported by the findings of Sogami et al.
(30, 42), who reported for BSA that the initial part of the N-F
transition was shifted to higher pH and the acid expansion was moved to
lower pH by increasing the salt concentration, especially by using
strongly binding anions such as ClO4
,
which dissociate hydrophilic and strengthen hydrophobic interfaces. Based on these findings we conclude that the major structural changes
in the N-F transition of HSA arise from domain III, as has previously
been shown for a C-terminal fragment of BSA (13) underlining that
HSA-DOM III as a stand-alone protein clearly reflects the structural
behavior of the C terminus of the native molecule.
With HSA-DOM I only a minor decrease in helix content is observed in
the region of the N-F transition of HSA, whereas a marked structural
change occurs in the pH region of the acid expansion of HSA (Fig.
1B and Table I). This is in good agreement with the concept
that the albumin molecule is fully extended in the E-form, resulting
from a loss of inter-domain and inter-subdomain contacts and a
disruption of the structure in the hinge and link regions (1, 2).
HSA-DOM II undergoes a rearrangement of secondary structure in the pH
region between 6.5 and 4.0 (Fig. 1B), which surprisingly leads to a slight increase in helical content and a reduction in sheet
structure (Table I). As we have previously shown (3) the isoelectric
point of HSA-DOM II is 5.4, which is almost the midpoint of this
transition. It is conceivable that near the isoelectric point, where
ionic repulsion between side chains of the same charge is minimized,
hydrophobic interactions result in a rearrangement of secondary
structure. This suggests that HSA-DOM II has a very flexible structure,
which is not surprising since this domain has lost contacts to the two
neighboring domains, leading to two previously unexposed surface
patches, one at its N terminus and, more importantly, the second in the
central part of HSA-DOM II as judged from inspection of the crystal
structure. By further lowering the pH, an acid expansion-like
transition is observed, which is, however, not as pronounced as
compared with HSA-DOM I, HSA-DOM III, and HSA.
The partial structural restoration as it is observed with all four
proteins at strong acidic pH can be explained by a minimization of the
hydrophobic surface area, which is promoted by neutralization of
positively charged repulsive forces by chloride anions of HCl, as has
been reported by Goto et al. (20) and Fink et al.
(21) for many proteins.
In the alkaline pH range between pH 7.4 and 9.0, HSA displays a slight
reduction in helical content and a small increase in sheet structure,
whereas the changes in coil structure are not significant (Fig.
1B and Table I). These findings are in good agreement with
the data for BSA reported by Era et al. (22) in the absence
of salt. The recombinant domains did not show significant alterations
in their secondary structure content in the alkaline pH region (Fig.
1B and Table I). The N-B isomerization is interpreted to be
"a structural fluctuation, a loosening of the molecule with higher
configurational adaptability" (2). The B-form in the absence of added
salt might be a state where mutual movement of subdomains, connected by
flexible hinge regions, takes place, accompanied by fluctuations of the
structures of the subdomains themselves relative to each other (22). It
is therefore possible that the main losses in secondary structure are
affecting the two interdomain helices (h10DOM I-h1DOM
II, h10DOM II-h1DOM III) of HSA and that
the secondary structural integrity of a domain per se is not
impaired in the N-B transition as supported by our data presented here.
Tryptophanyl Fluorescence--
To explore further the unexpected
structural changes of HSA-DOM II, tryptophanyl fluorescence
measurements were performed, since the lone tryptophanyl residue of HSA
is located almost centrally in helix 2 of domain II. The position of
the energy maximum (
max) from the arising emission
spectrum depends on the properties of the environment of the
tryptophanyl residue (43). The fluorescence intensity depends upon the
degree of exposure of the tryptophanyl side chain to the polar, aqueous
solvent and upon its proximity to specific quenching groups, such as
protonated carboxyl, protonated imidazole, deprotonated
-amino
groups, and tyrosinate anions (44, 45).
With HSA, we obtained pH profiles of Flem max
(where Fl is fluorescence intensity) in the acid pH region
showing a two-step change (Fig. 2A), one corresponding to
the N-F transition and the other to the acid expansion, as reported
previously for HSA (16, 23, 24) and for BSA (46, 47). The major changes in Flem max were complete at pH 4.5, which is
approximately at the onset of the N-F transition under conditions where
salt is added. It was reported (41) that delipidated BSA and albumin without added salt show a shift of the N-F transition to higher pH
regions. The observed shift of the energy maximum to shorter wavelength
of HSA in the N-F transition (Fig. 2A) was attributed to
sandwiching of the indole side chain in a rigid portion of the protein
matrix (24).
The pH-dependent decrease of the tryptophanyl fluorescence
of HSA at the onset of the N-F transition may be attributed to quenching by protonated imidazole and carboxyl groups, resulting from
protonation of such residues in the vicinity of Trp-214. Three amino
acids with carboxylate side chains (Glu-292 of domain II and Glu-450
and Asp-451 of domain III) and one histidine residue (His-242 of domain
II) are found within 10 Å distance from Trp-214, based on the atomic
coordinates of HSA (Protein Data Bank entries 1UOR (48) and 1AO6 (49)).
In addition, Cowgill (50) reported that loss of helical conformation is
correlated with a decrease in fluorescence intensity, which is the case
in the N-F transition, as discussed in the far-UV CD section. The
reduction in fluorescence intensity below pH 3.5 may arise from
quenching by protonation of carboxylate groups, whereas the increase in fluorescence at pH values below 2.5 can be attributed to restoration of
secondary structure at strong acidic pH without added salt (20, 21),
which was reported to trigger fluorescence intensity (50).
Consequently, a more hydrophobic environment of Trp-214 may be created,
leading to increased tryptophanyl fluorescence intensity as described
by Halfman and Nishida (44, 45).
The observed decreases of
max and fluorescence intensity
of HSA in the pH region from 7.4 to 9.0 (Fig. 2A) might
either be due to changes in the secondary structure as discussed
in the far-UV CD section and/or to quenching of the tryptophanyl
fluorophor by deprotonation of groups that are in close proximity to
the indole chromophore, such as
-amino groups of lysyl residues. Two
such residues are found in the crystal structures of HSA, viz. Lys-199 at 3.7 Å and Lys-195 at 7.4 Å distance to
Trp-214.
Profound differences between the fluorescence behavior of the lone
tryptophanyl residue in HSA-DOM II and in HSA at pH 7.4 are highlighted
by the 2.6-fold lower quantum yield of HSA-DOM II and the pronounced
shift of the emission maximum to shorter wavelength (Fig.
2A), denoting a dramatically changed microenvironment of
this residue in HSA-DOM II. As can be deduced from the crystal structures of human serum albumin, Trp-214 acts as an important stabilizer (by hydrophobic packing force) for the interface between subdomain IIA and IIIA (1). This hydrophobic area, which is centered in
the crystal structure of domain II, loses its natural counterpart when
expressed in the form of a single domain, leading to modified water
accessibility of the tryptophanyl residue in the recombinant protein,
thereby affecting the alterations in fluorescence behavior of the
tryptophanyl residue in HSA-DOM II. The reduced fluorescence intensity
may indicate an impairment of the helix harboring the lone tryptophanyl
in the native molecule, which is supported by the reduced helical
content of HSA-DOM II compared with HSA at pH 7.4 (Table I). By
using light meromyosin, a helical muscle protein, Cowgill (50)
demonstrated a 3-fold reduction of the tryptophanyl fluorescence
intensity by disaggregation of the helical conformation and attributed
this observation to the quenching by peptide carbonyl groups in
disordered polypeptides. The shifted wavelength maximum of HSA-DOM II
compared with HSA may be due to a more hydrophobic environment of the
tryptophanyl residue and/or sandwiching of the side chain in the rigid
portion of the protein matrix, as has been described Eftink and Ghiron (24) for HSA.
In the weak acid pH region, there is a sigmoidal 2.4-fold increase in
fluorescence intensity of HSA-DOM II ending near pH 4.0 (Fig.
2A). Interestingly, at pH 4.0 HSA-DOM II and HSA have almost
superimposable tryptophanyl fluorescence spectra suggesting similar
microenvironments encircling this residue in both proteins. The
pronounced increase in fluorescence intensity of HSA-DOM II between pH
7.4 and 4.0 is correlated with the secondary structural rearrangement
observed by far-UV CD in the same pH region. It has been reported that
loss of helical conformation resulted in decreased fluorescence (see
above) (50). Conversely, we detect an increased
-helical content
with decreasing pH (Fig. 1B and Table I), which therefore
may trigger the fluorescence of the tryptophanyl residue in HSA-DOM II.
In addition, Steiner and Edelhoch (51) reported that an increase in
intensity in the acid pH region is very likely to be connected with a
definite conformational change in the protein structure, because all
side chains that are known to quench the tryptophanyl fluorescence
intensity become protonated in this pH region and should therefore
quench the fluorescence (tryptophanyl fluorescence quenching groups:
-COOH, protonated imidazole, deprotonated
-NH2, -SH,
-S-S-, tyrosinate anion).
The spectra of the tryptophanyl residues of HSA and HSA-DOM II in 9.5 M urea (data not shown) are superimposable and show reduced
intensity caused by collisional quenching with the surrounding solvent
molecules with an emission maximum red-shifted to approximately 349 nm,
which is characteristic for a fully exposed tryptophanyl residue (24,
52).
In the weak alkaline pH range, the fluorescence intensity of HSA-DOM II
increases, which is accompanied by a shift of the emission maximum to
higher wavelength (Fig. 2A). The decrease in fluorescence
quenching in this pH region may be due to the deprotonation of
imidazole side chains with unusually high pK, which are
known to be located in domain II of HSA (17); however, the reduction of
the emission maximum suggests a structural transition in the zone
surrounding the tryptophanyl residue in HSA-DOM II.
Tyrosyl Fluorescence--
The fluorescence of proteins originates
almost entirely from the tyrosyl and tryptophanyl residues. In proteins
that lack tryptophanyl residues (class A, tryptophanyl-free proteins),
tyrosyl fluorescence is used as a probe for conformational changes
(53).
HSA-DOM I harbors seven tyrosyl residues. As indicated by the crystal
structures (Protein Data Bank entries: 1UOR (48) and 1AO6 (49)) four of
them (residues 30, 138, 140, and 161) are located in helical regions,
and all of them are at least minimally exposed to the solvent. We
observed a significant increase in tyrosyl fluorescence intensity of
HSA-DOM I in the pH region from 6.0 to 3.5 (Fig. 2B).
Inspection of the atomic coordinates of HSA shows that two carboxylate
side chains, Asp-38 and Asp-108, are within 5 Å of Tyr-84 and Tyr-148,
respectively. As has been demonstrated by Cowgill (54), carboxylate
groups serve as acceptors for the phenolic proton in the excited state
and thus are among the known quenchers for tyrosyl fluorescence. In
addition, it was reported that tyrosyl fluorescence is strongly
quenched by hydrogen bonding of the phenolic hydroxyl to carbonyl or
amide groups that could be supplied by the protein backbone and/or by side chains of asparagine and glutamine next to tyrosyl residues (53,
55, 56). As a matter of fact, hydrogen bonds between the OH group of
Tyr-30 and the amide side chain of Asn-99, as well as between the OH
group of Tyr-84 and backbone carbonyl of Gln-33 are strongly indicated
by the atomic coordinates of HSA. Therefore, protonation of the
aspartate side chains mentioned above accompanied by structural changes
which lead to disruption of these hydrogen bondings may explain the
observed rise in fluorescence intensity. All this suggests a
rearrangement of tertiary rather than of secondary structure of HSA-DOM
I in the region of the N-F transition of HSA, which is corroborated by
the results of near-UV CD measurements discussed below.
Three out of the four tyrosyl residues of HSA-DOM III are known to be
located in helical regions (residues 401, 411, and 452 of HSA) (Protein
Data Bank entries 1UOR (48) and 1AO6 (49)). As the pH of a HSA-DOM III
solution is reduced to pH 4.0 there is a sharp sigmoidal decrease in
the tyrosyl fluorescence intensity and a slight increase in the
emission maximum (Fig. 2B). This decrease in fluorescence
intensity may be due to a loss of helical structure around the three
tyrosyl residues located in
-helical regions, in conformity with the
pronounced reduction of helical content that we observed in the
identical pH range, as described above in the far-UV CD section.
Similar observations have been made by Cowgill (54) in the case of
helical muscle proteins. In addition, no carboxylate side chains that
could potentially trigger the fluorescence by their protonation can be
found in 5 Å surrounding the four tyrosyl residues. By further
reduction of the pH of the solution, the fluorescence rises
continuously, which may be ascribed to the disruption of hydrogen
bondings between the hydroxyl groups of tyrosyl residues in HSA-DOM III
and carbonyl groups of the peptide backbone (Tyr-452 to Asn-429 and
Tyr-497 to Lys-534) (55) emphasized by the loss of secondary structure of HSA-DOM III in the F-E transition.
By increasing the pH of a HSA-DOM III solution, the intrinsic tyrosyl
fluorescence decreases, whereas a shoulder in the emission spectrum
near 350 nm occurs (data not shown). These findings strongly suggest
the deprotonation of the phenolic hydroxyl group of some tyrosyl
residues in HSA-DOM III, as was suggested previously (25, 54, 57). In
addition, Edelhoch et al. (57) reported that significant
inhibition of phenol emission occurs by uncharged amino groups. In this
pH region some lysyl residues may be deprotonated and lead to quenching
of tyrosyl fluorescence. In fact, in the crystal structure of HSA,
amino groups of lysyl residues are found in close proximity (5 Å surrounding) to all 4 tyrosyl residues of HSA-DOM III: Tyr-401 to
Lys-525, Tyr-411 to Lys-414, Tyr-452 to Lys-432 and Tyr-497 to Lys-534.
All these findings and the fact that HSA-DOM III undergoes only minor
changes in secondary structure in the slightly alkaline pH region
provide evidence that the observed decrease in fluorescence intensity
of HSA-DOM III is not correlated with a structural change, which in
addition is strongly supported by the near-UV CD results discussed below.
Near-UV CD--
CD spectra in the near-UV region provide
information about the asymmetry of the structure around the aromatic
amino acid side chains and disulfide bridges and therefore on
fluctuations in the tertiary structure of a protein. The main
contributions to the ellipticity from tryptophanyl and tyrosyl groups
are obvious above 265 nm, with the largest maxima around 279, 284, and
291 nm for tryptophanyl, around 277 nm for tyrosyl, and around 255, 261, and 268 nm for phenylalanine residues. The ellipticity of S-S
bridges in proteins can be significant from 320 to 250 nm (58-61).
The observed alterations in ellipticity of HSA in the acid pH range
(Fig. 3A) reflect the tertiary structural alterations in the
N-F and F-E transition, in correlation with the loss of secondary
structure described above. These findings are in close agreement with
previous results obtained with BSA (30). The observed decrease of
[
]290-300 in the spectrum at pH 4.0 was ascribed to
the immobilization of the tryptophanyl residues of BSA (30). Leonard
and Foster (37) reported that approximately four buried tyrosyl
residues of BSA appear to become solvent-exposed during the acid
expansion, whereas none do so in the N-F transition. This may, in
addition to the environmental perturbations of the disulfide bridges,
be an explanation for the overall enhancement of the ellipticity and
the loss in fine structure below 280 nm between pH 4.0 and 2.0. The
residual near-UV CD signals at pH 2.0, which are significant compared
with the spectrum at 9.5 M urea, strongly suggest the
existence of tertiary packing, at least around aromatic residues and
disulfide bridges even at this low pH.
The alterations in the spectra between pH 7.4 and 9.0 demonstrate
tertiary structural changes in the N-B transition of HSA (Fig.
3A). This was ascribed to environmental perturbations of the
17 disulfides in BSA, such as variations in the dihedral angles, with
some contribution of phenylalanine and tyrosyl residues (29, 30), which
were shown by UV difference spectroscopy to gain increased
accessibility in this pH range (62). In addition, a slight reduction in
ellipticity in the region between 280 and 300 nm emerged, which might
be due to an immobilization of the tryptophanyl side chain, as was
described in the case of the N-F transition of BSA by Sogami et
al. (30) and is supported by the observed changes in the
tryptophanyl fluorescence discussed above.
The spectra of the three recombinant domains are dominated by the large
number of disulfide bridges analogous to HSA, whereas some difference
in fine structure is obvious, which may be owing to different relative
amounts of aromatic amino acid residues (Fig. 3, B-D). The
general similarity of the spectra of HSA, HSA-DOM I, HSA-DOM II, and
HSA-DOM III at pH 7.4 reflects their structural, evolutionary-based
relationship and emphasizes that the recombinant domains as stand-alone
proteins have the ability to adopt folds that are similar to their
respective structure in the context of the whole protein.
In the pH region of the N-F transition of HSA, all three domains
display increases in ellipticity of the minima at 262 and 268 nm (Fig.
3, B-D), which may be due to loss of asymmetry around disulfide bridges and/or aromatic residues, indicating disruption of
tertiary structure. In addition, major global changes with additional
minima in the spectra of HSA-DOM II occur between pH 7.4 and 4.0. This
may reflect dramatic changes in the tryptophanyl environment, supported
by the observed 2.4-fold increase in fluorescence intensity and the
secondary structural changes (Fig. 2A and Fig. 1B). Whereas the pH-dependent changes of the
spectra of HSA-DOM II and HSA-DOM III coincide with the observed
alterations in secondary structure and tryptophanyl and tyrosyl
fluorescence respectively, the most striking result of our CD
measurements in the near ultraviolet region is the fact that HSA-DOM I
undergoes fluctuations in tertiary structure that are accompanied by
only a small loss in secondary structure, which could so far only be
deduced from experiments with larger fragments (12). HSA-DOM I shows
flattening of the shoulder near 255 nm as the pH is diminished to 4.0 and also as it is increased to 9.0, indicating perturbations of
phenylalanine residues. An opening of the crevice harboring Cys-34 has
been reported to occur during both the N-F and the N-B transition of BSA (63, 64). The crystal structure of HSA shows that Phe-26 and Phe-37
are located in the same crevice, and it is therefore possible that the
observed flattening of the shoulder at 255 nm may partly be attributed
to perturbations of these particular residues.
By reducing the pH further, all three recombinant proteins lose
tertiary structure as indicated by the rise in ellipticity at 262 and
268 nm and the loss of fine structure (Fig. 3, B-D), in
agreement with the observed decrease of the secondary structure content
in the region of the acid expansion of HSA. By inspection of the
spectra of HSA-DOM I, HSA-DOM II, and HSA-DOM III at pH 2.0 and 9.5 M urea, which represents the fully denaturated state as
indicated by the spectra in the far-UV region (Fig. 1A), it becomes evident that HSA-DOM I and HSA-DOM III, similar to HSA, display
significant tertiary structural elements even at pH 2.0. It has been
reported for some proteins (20, 21), especially for those that are
heavily cross-linked by disulfide bridges, as is the case for albumin
and its domains, that the intramolecular charge-charge repulsion is
insufficient to cause complete unfolding in the range of pH 2 in the
absence of salt. This may serve as an explanation why we could observe
residual secondary and tertiary structure with HSA, HSA-DOM I, and
HSA-DOM III, even at this low pH.
In contrast, the ellipticities of HSA-DOM II at pH 2.0 and 9.5 M urea are comparable (Fig. 3C). The fact that
the spectra are different in shape despite the supposed complete
denaturation at these conditions may be explained by residual tertiary
packing around the lone tryptophanyl residue, supported by the
difference in its fluorescence intensity and emission maximum at pH 2.0 and 9.5 M urea, respectively. Similar observations with a
number of proteins including bovine serum fetuin have been described
(Ref. 65 and references therein). Therefore we speculate that HSA-DOM II transforms to a molten globule-like state in the acidic pH region
with pronounced loss of tertiary but preserved secondary structure
(66).
At pH 9.0, HSA-DOM I and HSA-DOM II display a slight enhancement of the
CD signal at 262 and 268 nm, some fluctuations in fine structure most
evident in the spectrum of HSA-DOM I in the wavelength region above 285 nm, as well as a flattening of the shoulder near 255 nm, indicating a
perturbation of Phe-26 and Phe-37 in the pH region of the N-B
transition as discussed above. Since there are no significant changes
in the secondary structural content of these two proteins, these
findings clearly denote a tertiary structural rearrangement, which has
been speculated to happen in the N-terminal region of the native HSA
and BSA molecules during the N-B transition (2, 11, 17, 64, 67-69). No
changes in the spectra of HSA-DOM III are observable in this pH region which, in the context with the observations discussed above, leads us
to the conclusion that HSA-DOM III is not involved in the N-B transition of the intact molecule.
Conclusion--
It is clear that complex chemical intra- and
inter-domain forces stabilize the albumin structure and that an
isolated domain cannot be expected to fully reflect its behavior in the
context of the whole protein because of the absence of all inter-domain contacts. This is especially true for HSA-DOM II which, due to its
central position in the albumin molecule, experiences the greatest
proportional loss of framework structure when expressed as a
stand-alone protein, underlined by the proposed formation of a molten
globule-like state of HSA-DOM II at acidic pH in contrast to the other
two recombinant domains. However, it is evident from the work presented
here that certain features, e.g. the origin of the
molecular rearrangements during the N-F and N-B transition, can be
attributed to specific albumin domains unequivocally, in particular to
HSA-DOM III and HSA-DOM I, respectively. In conclusion we were able to
demonstrate that the recombinant domains of HSA represent powerful
tools for the dissection and study of important structural and
functional characteristics of the native molecule.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Tilman Voss (Boehringer
Ingelheim, Austria) for use of the CD equipment, Dr. Christian Obinger
(Institute of Chemistry, University of Agricultural Sciences, Vienna)
for use of the fluorescence spectrometer, and Eva Obermayr for expert technical help.
 |
FOOTNOTES |
*
This work was supported in part by the Austrian Fonds zur
Förderung der Wissenschaftlichen Forschung Grant P11280-MED and Jubiläumsfonds der Oesterreichischen Nationalbank Grant
P7277-MED.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported in part by New Century Pharmaceuticals, Inc.
To whom correspondence should be addressed: Institute of
Applied Microbiology, University of Agricultural Sciences, Muthgasse 18, A-1190 Vienna, Austria. Tel.: +43-1-36006-6240; Fax:
+43-1-36006-6652; E-mail: ruker@mail.boku.ac.at.
 |
ABBREVIATIONS |
The abbreviations used are:
HSA, human serum
albumin;
BSA, bovine serum albumin;
DOM, domain.
 |
REFERENCES |
| 1.
|
Carter, D. C.,
and Ho, J. X.
(1994)
Adv. Protein Chem.
45,
153-203[Medline]
[Order article via Infotrieve]
|
| 2.
|
Peters, T., Jr.
(1996)
All About Albumin: Biochemistry, Genetics, and Medical Applications
, Academic Press, Inc., New York
|
| 3.
|
Dockal, M.,
Carter, D. C.,
and Rüker, F.
(1999)
J. Biol. Chem.
274,
29303-29310[Abstract/Free Full Text]
|
| 4.
|
Era, S.,
Ashida, H.,
Nagaoka, S.,
Inouye, H.,
and Sogami, M.
(1983)
Int. J. Pept. Protein Res.
22,
333-340[Medline]
[Order article via Infotrieve]
|
| 5.
|
Era, S.,
and Sogami, M.
(1998)
J. Pept. Res.
52,
431-442[Medline]
[Order article via Infotrieve]
|
| 6.
|
Wilting, J.,
Weideman, M. M.,
Roomer, A. C.,
and Perrin, J. H.
(1979)
Biochim. Biophys. Acta
579,
469-473[Medline]
[Order article via Infotrieve]
|
| 7.
|
t' Hart, B. J.,
Wilting, J.,
and de Gier, J. J.
(1986)
Biochem. Pharmacol.
35,
1005-1009[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Bos, O. J.,
Remijn, J. P.,
Fischer, M. J.,
Wilting, J.,
and Janssen, L. H.
(1988)
Biochem. Pharmacol.
37,
3905-3909[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Bos, O. J.,
Fischer, M. J.,
Wilting, J.,
and Janssen, L. H.
(1988)
Biochim. Biophys. Acta
953,
37-47[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Braam, W. G.,
Hilak, M. C.,
Harmsen, B. J.,
and Van Os, G. A.
(1974)
Int. J. Pept. Protein Res.
6,
21-29[Medline]
[Order article via Infotrieve]
|
| 11.
|
Hilak, M. C.,
Harmsen, B. J.,
Braam, W. G.,
Joordens, J. J.,
and Van Os, G. A.
(1974)
Int. J. Pept. Protein Res.
6,
95-101[Medline]
[Order article via Infotrieve]
|
| 12.
|
Khan, M. Y.,
and Salahuddin, A.
(1984)
Eur. J. Biochem.
141,
473-475[Medline]
[Order article via Infotrieve]
|
| 13.
|
Khan, M. Y.
(1986)
Biochem. J.
236,
307-310[Medline]
[Order article via Infotrieve]
|
| 14.
|
Reed, R. G.,
Feldhoff, R. C.,
Clute, O. L.,
and Peters, T., Jr.
(1975)
Biochemistry
14,
4578-4583[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Geisow, M. J.,
and Stuchbury, T.
(1977)
Biochem. J.
161,
619-625[Medline]
[Order article via Infotrieve]
|
| 16.
|
Geisow, M. J.,
and Beaven, G. H.
(1977)
Biochem. J.
163,
477-484[Medline]
[Order article via Infotrieve]
|
| 17.
|
Bos, O. J.,
Labro, J. F.,
Fischer, M. J.,
Wilting, J.,
and Janssen, L. H.
(1989)
J. Biol. Chem.
264,
953-959[Abstract/Free Full Text]
|
| 18.
|
Provencher, S. W.,
and Glöckner, J.
(1981)
Biochemistry
20,
33-37[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Provencher, S. W.
(1982)
Comput. Phys. Commun.
27,
229-242
|
| 20.
|
Goto, Y.,
Calciano, L. J.,
and Fink, A. L.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
573-577[Abstract/Free Full Text]
|
| 21.
|
Fink, A. L.,
Calciano, L. J.,
Goto, Y.,
Kurotsu, T.,
and Palleros, D. R.
(1994)
Biochemistry
33,
12504-12511[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Era, S.,
Itoh, K. B.,
Sogami, M.,
Kuwata, K.,
Iwama, T.,
Yamada, H.,
and Watari, H.
(1990)
Int. J. Pept. Protein Res.
35,
1-11[Medline]
[Order article via Infotrieve]
|
| 23.
|
Chen, R. F.
(1966)
Biochim. Biophys. Acta
120,
169-171[Medline]
[Order article via Infotrieve]
|
| 24.
|
Eftink, M. R.,
and Ghiron, C. A.
(1976)
Biochemistry
15,
672-680[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Pundak, S.,
and Roche, R. S.
(1984)
Biochemistry
23,
1549-1555[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Sjoholm, I.,
and Ljungstedt, I.
(1973)
J. Biol. Chem.
248,
8434-8441[Abstract/Free Full Text]
|
| 27.
|
Uversky, V. N.,
Narizhneva, N. V.,
Ivanova, T. V.,
and Tomashevski, A. Y.
(1997)
Biochemistry
36,
13638-13645[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Sjodin, T.,
Hansson, R.,
and Sjoholm, I.
(1977)
Biochim. Biophys. Acta
494,
61-75[Medline]
[Order article via Infotrieve]
|
| 29.
|
Noel, J. K.,
and Hunter, M. J.
(1972)
J. Biol. Chem.
247,
7391-7406[Abstract/Free Full Text]
|
| 30.
|
Sogami, M.,
Era, S.,
Nagaoka, S.,
and Inouye, H.
(1982)
Int. J. Pept. Protein Res.
19,
263-269[Medline]
[Order article via Infotrieve]
|
| 31.
|
Lee, J. Y.,
and Hirose, M.
(1992)
J. Biol. Chem.
267,
14753-14758[Abstract/Free Full Text]
|
| 32.
|
Phelps, R. A.,
and Cann, J. R.
(1956)
J. Biol. Chem.
78,
3539-3540
|
| 33.
|
Cann, J. R.,
and Phelps, R. A.
(1957)
J. Biol. Chem.
79,
4672-4677
|
| 34.
|
Cann, J. R.
(1958)
J. Biol. Chem.
80,
4263-4264
|
| 35.
|
Cann, J. R.
(1971)
Biochemistry
10,
3707-3712[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Cann, J. R.
(1971)
Biochemistry
10,
3713-3722[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Leonard, W. J.,
and Foster, J. F.
(1961)
J. Biol. Chem.
236,
2662-2669[Free Full Text]
|
| 38.
|
Moore, W. E.,
and Foster, J. F.
(1968)
Biochemistry
7,
3409-3417[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Sogami, M.,
Petersen, H. A.,
and Foster, J. F.
(1969)
Biochemistry
8,
49-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Lund, M.,
Bjerrum, O. J.,
and Bjerrum, M. J.
(1999)
Eur. J. Biochem.
260,
470-476[Medline]
[Order article via Infotrieve]
|
| 41.
|
Sogami, M.,
and Foster, J. F.
(1968)
Biochemistry
7,
2172-2182[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Sogami, M.
(1971)
J. Biochem. (Tokyo)
69,
819-822[Free Full Text]
|
| 43.
|
Steinhardt, J.,
Krijn, J.,
and Leidy, J. G.
(1971)
Biochemistry
10,
4005-4015[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Halfman, C. J.,
and Nishida, T.
(1971)
Biochim. Biophys. Acta
243,
284-293[Medline]
[Order article via Infotrieve]
|
| 45.
|
Halfman, C. J.,
and Nishida, T.
(1971)
Biochim. Biophys. Acta
243,
294-303[Medline]
[Order article via Infotrieve]
|
| 46.
|
Sogami, M.,
Nagaoka, S.,
Ito, K. B.,
and Sakata, S.
(1973)
|